Ticker Details
Dyadic International, Inc.
IPO Date:	February 1, 2008
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$25.89M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 3.90%
Avg Daily Range (30 D):	$0.05 | 5.93%
Avg Daily Range (90 D):	$0.04 | 4.91%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.4M
Avg Daily Volume (90 D):	.18M

Trade Size
Avg Trade Size (Sh.):	239
Avg Trade Size (Sh.) (30 D):	407
Avg Trade Size (Sh.) (90 D):	397

Institutional Trades
Total Institutional Trades:	20
Avg Institutional Trade:	$2.11M
Avg Institutional Trade (30 D):	$.84M
Avg Institutional Trade (90 D):	$.84M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.07M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	600.59K

News

May 21, 2026 @ 7:45 PM Skyline Corporate Communications Group, LLC Announ... Source: Skyline Corporate Communications Group, Llc

May 1, 2025 @ 7:00 PM Dyadic to Report First Quarter 2025 Financial Resu... Source: N/A

Mar 11, 2025 @ 9:28 AM Industrial Enzymes Global Industry Forecast Report... Source: Researchandmarkets.Com

Oct 9, 2024 @ 12:00 PM Dyadic Expands Global Presence with Participation ... Source: N/A

Jun 28, 2024 @ 12:30 PM Dyadic International, Inc. and Proliant Health and... Source: Dyadic International, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.21	$-.05	$-.06
Diluted EPS	$-.21	$-.05	$-.06
Revenue	$3.81M	$1.11M	$.57M
Gross Profit	$.99M	$.32M	$.18M
Net Income / Loss	$-7.29M	$-1.95M	$-1.57M
Operating Income / Loss	$-7.09M	$-1.9M	$-1.54M
Cost of Revenue	$2.81M	$.79M	$.38M
Net Cash Flow	$-.66M	$M	$-1.3M
PE Ratio